Plain-English translation of NCT04834544 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new treatment called DCVAC/OvCa as a maintenance therapy — meaning you would receive it after completing your standard first-line chemotherapy. The study wants to see if this medication, added to your regular care, is safe and helps prevent the cancer from coming back in people with advanced ovarian, fallopian tube, or primary peritoneal cancer.
After chemotherapy, advanced ovarian cancer often returns. Researchers believe that adding a maintenance treatment like this medication might help keep the cancer away longer and improve survival, but they need to test whether it's safe and actually works.
You likely qualify if…
You likely don't qualify if…
You would first complete your standard chemotherapy as planned. Then, you would be randomly assigned to either receive the new maintenance medication or a placebo (a dummy treatment with no active drug) for a period of time. Neither you nor your doctors will know which group you're in. You will have regular clinic visits to check your health, blood work, and how you are tolerating the treatment. The study involves about 75 people total across the research center.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
China